Six months after launch, a startup founded by three leaders in the blood testing...
In public, hospitals rave about artificial intelligence. But on the front lines,...
Sen. Bill Cassidy’s new perch as the top Republican on the Senate health committ...
The CEOs of seven major health insurers together made more than $335 million in ...
Already, rumors are flying that vaccine opponents in other states will try to fo...
The FDA approved a new drug from Seres Therapeutics that uses bacteria to treat ...
Teladoc beat Wall Street revenue estimates in the 2023’s first quarter — a feat ...
An early-stage Alzheimer’s disease treatment from Alnylam Pharmaceuticals showed...
Few details had been made public about the death of the first patient in a desig...
The mega-deal between Kaiser Permanente and Geisinger marks the biggest proposed...
The House Oversight Committee is going to hold a hearing on the results of an in...
The European Commission unveiled a long-awaited proposed update for how the cont...
rAAV-Olig001 is a new vector from a class of recombinant AAVs (rAAVs) that selec...
Packaging plays a critical part in the pharmaceuticals and medical devices indus...
Adcentrx’s ADRX-0706 is anticipated to enter a first-in-human Phase I clinical t...
VYD222 is being assessed in an ongoing Phase I healthy volunteer clinical trial ...
